Zifeng Yang
Impact in
- Pharmacology top 0.2%
- Pharmacological Effects of Natural Compounds
Papers in
- Epidemiology 92
- Influenza Virus Research Studies 73
- Respiratory viral infections research 44
-
- SARS-CoV-2 and COVID-19 Research 31
- COVID-19 Clinical Research Studies 18
- Viral gastroenteritis research and epidemiology 17
- Co-authors
- Nanshan Zhong (37 shared papers)Runfeng Li (29 shared papers)Haiming Jiang (23 shared papers)Jin Zhao (14 shared papers)Zhi‐Hong Jiang (20 shared papers)Beixian Zhou (12 shared papers)Yutao Wang (27 shared papers)Qinhai Ma (20 shared papers)
In The Last Decade
Zifeng Yang
175 papers receiving 4.5k citations
Zifeng Yang's Hit Papers
Peers
Comparison fields: 5 of 150
- Pharmacology 804
- Complementary and alternative medicine 681
- Infectious Diseases 1.4k
- Epidemiology 1.3k
- Immunology 675
Countries citing papers authored by Zifeng Yang
This map shows the geographic impact of Zifeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zifeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zifeng Yang more than expected).
Fields of papers citing papers by Zifeng Yang
This network shows the impact of papers produced by Zifeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zifeng Yang. The network helps show where Zifeng Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zifeng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) Hit paper breakdown → | 2020 | 495 |
| 2 | Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial Hit paper breakdown → | 2020 | 338 |
| 3 | 2017 | 195 | |
| 4 | 2020 | 163 | |
| 5 | 2013 | 135 | |
| 6 | 2017 | 118 | |
| 7 | 2013 | 117 | |
| 8 | 2020 | 98 | |
| 9 | 2020 | 84 | |
| 10 | 2017 | 81 | |
| 11 | 2017 | 78 | |
| 12 | 2013 | 77 | |
| 13 | 2015 | 71 | |
| 14 | 2017 | 62 | |
| 15 | 2020 | 60 | |
| 16 | 2019 | 59 | |
| 17 | 2020 | 55 | |
| 18 | 2012 | 53 | |
| 19 | 2018 | 53 | |
| 20 | 2013 | 53 |
About Zifeng Yang
Zifeng Yang is a scholar working on Epidemiology, Infectious Diseases, Immunology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 183 papers that have together received 4.6k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (73 papers), Respiratory viral infections research (44 papers), SARS-CoV-2 and COVID-19 Research (31 papers), Immune Response and Inflammation (25 papers), interferon and immune responses (23 papers), COVID-19 Clinical Research Studies (18 papers), Viral gastroenteritis research and epidemiology (17 papers) and Animal Disease Management and Epidemiology (10 papers). The work is most often cited by research in Pharmacology (804 citations), Complementary and alternative medicine (681 citations), Infectious Diseases (1.4k citations), Epidemiology (1.3k citations) and Immunology (675 citations). Zifeng Yang has collaborated with scholars based in China, Macao and Hong Kong. Frequent co-authors include Nanshan Zhong, Runfeng Li, Haiming Jiang, Jin Zhao, Zhi‐Hong Jiang, Beixian Zhou, Yutao Wang, Qinhai Ma, Wenbo Huang and Chufang Li. Their work appears in journals such as Journal of Ethnopharmacology, Phytomedicine, Scientific Reports, International Immunopharmacology and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.